跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIVOSTIN levocabastine hydrochloride 0.54 mg/mL nasal spray solution bottle - TGA Drug Approval Details
Approvals
/
TGA
/
LIVOSTIN levocabastine hydrochloride 0.54 mg/mL nasal spray solution bottle
Approved
STANDARD
LIVOSTIN levocabastine hydrochloride 0.54 mg/mL nasal spray solution bottle
Johnson & Johnson Pacific Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
882e7b9b78dc0f4f
Company
Johnson & Johnson Pacific Pty Ltd
Type
Standard
Approval Details
Approval Id
882e7b9b78dc0f4f
Product Name
LIVOSTIN levocabastine hydrochloride 0.54 mg/mL nasal spray solution bottle
Artg Id
48290
Artg Name
LIVOSTIN levocabastine hydrochloride 0.54 mg/mL nasal spray solution bottle
Sponsor
Johnson & Johnson Pacific Pty Ltd
Company Detail Path
/organization/johnson-and-johnson-pacific-pty-ltd
Artg Date
1994-05-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
882e7b9b78dc0f4f
Type
Standard
Back to TGA Approvals